Companies / iTeos Therapeutics, Inc.
iTeos Therapeutics, Inc.
ITOSCIK 1808865
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| May 15, 2025 | EcoR1 Capital, LLC 10% owner | Buy Open-market buy | Common Stock | $26.40M | +3.3M +44.66% | 10,688,978 | high |
| Jan 3, 2022 | Boxer Capital, LLC Director | Sell Open-market sale | Common Stock | $20.63M | -433K -9.96% | 3,912,113 | high |
| Mar 17, 2022 | Boxer Capital, LLC Director | Sell Open-market sale | Common Stock | $20.28M | -575K -15.47% | 3,142,058 | high |
| May 14, 2025 | EcoR1 Capital, LLC 10% owner | Buy Open-market buy | Common Stock | $12.29M | +1.7M +28.95% | 7,388,978 | high |
| Apr 1, 2021 | Ra Capital Management, L.P. Director | Other Other (per filing) | Common Stock | $9.91M | +290K | 289,843 | low |
| May 13, 2025 | Gadicke Ansbert 10% owner | Sell Open-market sale | Common Stock | $8.32M | -1.0M -23.01% | 3,452,797 | medium |
| Jan 4, 2022 | Gadicke Ansbert 10% owner | Sell Open-market sale | Common Stock | $6.67M | -159K -3.35% | 4,571,618 | medium |
| May 13, 2025 | Mpm Bioventures 2018, L.P. 10% owner | Sell Open-market sale | Common Stock | $5.08M | -630K -23.01% | 2,108,594 | medium |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| ITOS | — | 46565G104 |